Evaluation of Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects

Clinical trial NCT05805618 · UNKNOWN

Trial details

NCT number: NCT05805618
Sponsor: Syneos Health
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Gastroenteritis

Start date: 2024-07-01
Primary completion: 2024-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.